Jian Liu, PhDChief Scientific Officer and Site Head at Eternity Bioscience Inc., Cranbury, New Jersey
Jian Liu, PhD, is currently the Chief Scientific Officer and Site Head at Eternity Bioscience Inc., the Hengrui Medicine US R&D center, in charge of drug innovation. Previously Dr. Liu served as the Principal Scientist and External Lead in the External Discovery Chemistry Department at Merck. Dr. Liu has managed many projects on target validation, lead identification, and lead optimization, and has generated multiple clinical candidates that went into first-in-man, phase I, and phase II clinical trials. Dr. Liu is an expert in drug discovery on various therapeutic areas including osteoporosis, obesity, diabetes, cardiovascular disease, rheumatoid arthritis, oncology, infectious disease, pain and neuro-degenerative diseases.
Dr. Liu had experience in charge of outsourcing and collaborating with multiple external CRO companies. Based on his research work, Dr. Liu has published over 40 peer reviewed papers, and obtained more than 50 US and international patents. Dr. Liu got a Ph.D. degree in organic and computational chemistry from UCLA in 1998 and joined Merck in 2001. He was the 25th President of Sino-American Pharmaceutical Professionals Association (SAPA) and currently a member of the board of director. To recognize his significant contribution to the scientific research and community service, Dr. Liu was the proud recipient of the 2019 Outstanding 50 Asian Americans Award by the Asian American Business Development Center. Dr. Liu joined Eternity Bioscience Inc. in August 2020.